Revised SPC: Galzemic (galantamine hydrobromide) 4 mg/ml Oral Solution

SPC warns galantamine can cause bradycardia (common) and all types of atrioventricular node block (rare); and galantamine bioavailability increases during co-administration of paroxetine (CYP2D6 inhibitor), ketoconazole & erythromycin (CYP3A4 inhibitors) have been observed.

Source:

electronic Medicines compendium